Statistics
Publications
31
Citations
7.2K
H-Index
21
Active since
1996
Yen‐Hwa Chang is an author at Taipei Veterans General Hospital specializing in oncology, medicine, and kidney cancer.
Publications per year
1996–2024
31
31
Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma
Brian I. Rini, Elizabeth R. Plimack, V.P. Stus et al. · New England Journal of Medicine · 2019 · 3.4K citations · Full text
Medicine, Oncology, Pharmacology +9
Adjuvant Sunitinib in High-Risk Renal-Cell Carcinoma after Nephrectomy
Alain Ravaud, Robert J. Motzer, Hardev Pandha et al. · New England Journal of Medicine · 2016 · 777 citations
Medicine, Oncology, Pharmacotherapy +17
Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma
Toni K. Choueiri, Piotr Tomczak, Se Hoon Park et al. · New England Journal of Medicine · 2021 · 746 citations · Full text
Medicine, Oncology, Pharmacotherapy +13
Thomas Powles, Tibor Csőszi, Mustafa Özgüroğlu et al. · The Lancet Oncology · 2021 · 648 citations · Full text
Medicine, Oncology, Pharmacology +11
Michiel S. van der Heijden, Matthew D. Galsky, Yohann Loriot et al. · The Lancet Oncology · 2020 · 498 citations · Full text
Medicine, Oncology, Pharmacology +14
1–5 of 31